Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 218.25 CNY 0.11%
Market Cap: 131.7B CNY
Have any thoughts about
Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Revenue
10.9B CNY
Cost of Revenue
-6.1B CNY
Gross Profit
4.8B CNY
Operating Expenses
-1.3B CNY
Operating Income
3.5B CNY
Other Expenses
-455m CNY
Net Income
3.1B CNY

Income Statement
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
1 409
N/A
1 454
+3%
1 455
+0%
1 503
+3%
1 698
+13%
1 886
+11%
1 975
+5%
2 032
+3%
2 180
+7%
2 309
+6%
2 701
+17%
3 101
+15%
3 428
+11%
3 714
+8%
4 076
+10%
4 365
+7%
4 555
+4%
4 766
+5%
5 028
+5%
5 257
+5%
5 522
+5%
5 722
+4%
5 953
+4%
6 074
+2%
6 451
+6%
6 511
+1%
6 798
+4%
7 113
+5%
7 553
+6%
8 022
+6%
8 368
+4%
8 595
+3%
8 526
-1%
8 694
+2%
8 975
+3%
9 317
+4%
9 678
+4%
10 058
+4%
10 600
+5%
10 664
+1%
10 909
+2%
Gross Profit
Cost of Revenue
(715)
(735)
(732)
(743)
(867)
(1 008)
(1 057)
(1 030)
(1 088)
(1 195)
(1 494)
(1 805)
(2 043)
(2 115)
(2 330)
(2 504)
(2 605)
(2 754)
(2 934)
(3 053)
(3 174)
(3 198)
(3 328)
(3 384)
(3 517)
(3 584)
(3 771)
(3 819)
(3 840)
(3 968)
(4 189)
(4 412)
(4 614)
(4 735)
(4 964)
(5 164)
(5 264)
(5 363)
(5 748)
(5 876)
(6 118)
Gross Profit
694
N/A
719
+4%
723
+1%
760
+5%
831
+9%
878
+6%
919
+5%
1 003
+9%
1 091
+9%
1 114
+2%
1 207
+8%
1 297
+7%
1 385
+7%
1 599
+15%
1 746
+9%
1 861
+7%
1 950
+5%
2 012
+3%
2 094
+4%
2 204
+5%
2 348
+7%
2 524
+8%
2 624
+4%
2 690
+3%
2 933
+9%
2 927
0%
3 027
+3%
3 294
+9%
3 712
+13%
4 054
+9%
4 179
+3%
4 184
+0%
3 911
-7%
3 959
+1%
4 012
+1%
4 153
+4%
4 414
+6%
4 695
+6%
4 851
+3%
4 788
-1%
4 791
+0%
Operating Income
Operating Expenses
(295)
(284)
(276)
(292)
(313)
(368)
(380)
(419)
(448)
(523)
(534)
(573)
(610)
(712)
(727)
(756)
(748)
(768)
(795)
(829)
(908)
(954)
(1 002)
(1 023)
(1 140)
(1 116)
(1 079)
(1 154)
(1 055)
(1 320)
(1 302)
(1 217)
(1 138)
(1 136)
(1 079)
(1 044)
(1 159)
(1 448)
(1 362)
(1 346)
(1 256)
Selling, General & Administrative
(281)
(227)
(275)
(288)
(306)
(303)
(368)
(398)
(431)
(428)
(524)
(571)
(589)
(603)
(675)
(707)
(708)
(628)
(665)
(662)
(716)
(800)
(865)
(900)
(1 016)
(960)
(1 003)
(1 062)
(956)
(1 003)
(1 040)
(962)
(894)
(844)
(830)
(796)
(890)
(1 156)
(1 158)
(1 146)
(1 087)
Research & Development
0
(45)
0
0
0
(50)
0
0
0
(67)
0
0
(20)
(70)
0
0
(46)
(96)
(92)
(125)
(141)
(116)
(132)
(122)
(126)
(93)
(89)
(104)
(103)
(194)
(256)
(249)
(245)
(225)
(245)
(236)
(267)
(207)
(228)
(232)
(197)
Depreciation & Amortization
0
(11)
0
0
0
(14)
0
0
0
(26)
0
0
0
(47)
0
0
0
(49)
0
0
0
(48)
0
0
0
(83)
0
0
0
(126)
0
0
0
(74)
0
0
0
(104)
0
0
0
Other Operating Expenses
(13)
(1)
(2)
(4)
(7)
(1)
(12)
(20)
(18)
(2)
(10)
(2)
(1)
9
(52)
(49)
6
5
(39)
(43)
(51)
10
(6)
(1)
2
20
12
12
5
2
(6)
(6)
1
7
(4)
(11)
(2)
19
24
32
28
Operating Income
399
N/A
436
+9%
447
+3%
468
+5%
519
+11%
510
-2%
539
+6%
584
+8%
643
+10%
591
-8%
673
+14%
723
+8%
775
+7%
888
+15%
1 019
+15%
1 105
+9%
1 202
+9%
1 243
+3%
1 299
+4%
1 375
+6%
1 440
+5%
1 570
+9%
1 622
+3%
1 667
+3%
1 794
+8%
1 811
+1%
1 949
+8%
2 140
+10%
2 657
+24%
2 733
+3%
2 877
+5%
2 967
+3%
2 773
-7%
2 823
+2%
2 932
+4%
3 109
+6%
3 255
+5%
3 247
0%
3 489
+7%
3 442
-1%
3 534
+3%
Pre-Tax Income
Interest Income Expense
18
73
70
87
85
32
40
23
19
20
19
34
47
41
44
37
36
108
112
119
115
69
85
105
112
126
111
105
125
113
118
124
114
142
140
128
133
146
134
150
145
Non-Reccuring Items
0
(0)
0
0
0
0
0
0
0
(6)
(4)
(4)
(4)
19
6
22
22
(31)
10
(5)
(5)
(1)
5
5
5
41
42
42
43
27
28
36
38
10
11
4
1
1
2
4
5
Gain/Loss on Disposition of Assets
(2)
(0)
0
(3)
(3)
(3)
(3)
(1)
(1)
(0)
0
(0)
0
(1)
0
(1)
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
(1)
0
0
0
Total Other Income
15
10
9
10
11
11
11
8
5
5
3
1
1
(5)
(3)
(9)
(8)
8
7
14
18
7
12
11
7
2
(5)
(5)
(7)
(4)
(4)
(4)
(2)
3
2
1
0
(24)
(26)
(25)
(25)
Pre-Tax Income
430
N/A
518
+20%
526
+2%
563
+7%
612
+9%
550
-10%
587
+7%
614
+5%
666
+8%
609
-9%
690
+13%
755
+9%
819
+9%
942
+15%
1 065
+13%
1 154
+8%
1 250
+8%
1 328
+6%
1 428
+8%
1 503
+5%
1 568
+4%
1 645
+5%
1 724
+5%
1 788
+4%
1 917
+7%
1 979
+3%
2 097
+6%
2 284
+9%
2 818
+23%
2 869
+2%
3 019
+5%
3 122
+3%
2 923
-6%
2 978
+2%
3 086
+4%
3 241
+5%
3 388
+5%
3 369
-1%
3 599
+7%
3 570
-1%
3 659
+3%
Net Income
Tax Provision
(58)
(80)
(86)
(89)
(100)
(86)
(93)
(94)
(96)
(102)
(111)
(134)
(145)
(161)
(179)
(189)
(207)
(199)
(213)
(224)
(229)
(258)
(270)
(274)
(299)
(290)
(295)
(336)
(421)
(404)
(441)
(455)
(427)
(455)
(471)
(477)
(494)
(518)
(546)
(557)
(555)
Income from Continuing Operations
373
438
439
474
512
463
495
520
571
507
579
621
675
780
887
965
1 044
1 129
1 215
1 279
1 339
1 387
1 453
1 514
1 619
1 689
1 802
1 948
2 397
2 465
2 578
2 667
2 496
2 523
2 615
2 765
2 894
2 851
3 053
3 013
3 105
Income to Minority Interest
1
1
1
(0)
1
3
3
(0)
4
29
37
43
55
27
20
27
9
14
6
(7)
(7)
(13)
(16)
(21)
(24)
(18)
(33)
(26)
(43)
(33)
(23)
(37)
(24)
(51)
(62)
(66)
(70)
(54)
(51)
(34)
(25)
Net Income (Common)
373
N/A
439
+18%
440
+0%
474
+8%
513
+8%
467
-9%
497
+7%
520
+5%
575
+11%
536
-7%
616
+15%
664
+8%
730
+10%
807
+11%
907
+12%
991
+9%
1 052
+6%
1 143
+9%
1 221
+7%
1 272
+4%
1 332
+5%
1 374
+3%
1 438
+5%
1 493
+4%
1 594
+7%
1 672
+5%
1 769
+6%
1 922
+9%
2 354
+22%
2 432
+3%
2 555
+5%
2 631
+3%
2 472
-6%
2 472
0%
2 553
+3%
2 699
+6%
2 825
+5%
2 797
-1%
3 002
+7%
2 978
-1%
3 079
+3%
EPS (Diluted)
0.61
N/A
0.81
+33%
0.8
-1%
0.78
-3%
0.85
+9%
0.77
-9%
0.83
+8%
0.86
+4%
0.95
+10%
0.89
-6%
1.02
+15%
1.1
+8%
1.21
+10%
1.34
+11%
1.5
+12%
1.64
+9%
1.74
+6%
1.89
+9%
2.02
+7%
2.11
+4%
2.21
+5%
2.28
+3%
2.39
+5%
2.48
+4%
2.65
+7%
2.77
+5%
2.94
+6%
3.19
+9%
3.91
+23%
4.03
+3%
4.24
+5%
4.36
+3%
4.1
-6%
4.1
N/A
4.23
+3%
4.47
+6%
4.68
+5%
4.64
-1%
4.98
+7%
4.94
-1%
5.1
+3%

See Also

Discover More